We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA-Based Droplet System Rapidly Detects Bacterial Infection in the Bloodstream

By LabMedica International staff writers
Posted on 23 Nov 2014
Print article
Image: IC 3D technology rapidly detects bacterial infection in blood samples (Photo courtesy of University of California, Irvine).
Image: IC 3D technology rapidly detects bacterial infection in blood samples (Photo courtesy of University of California, Irvine).
A new test for bacterial infection in the bloodstream is based on an innovative DNA labeling and particle counting system.

Investigators at the University of California, Irvine (USA) recently described a new technology termed "Integrated Comprehensive Droplet Digital Detection" (IC 3D) that can selectively detect bacteria directly from milliliters of diluted blood. IC 3D is a one-step, culture- and amplification-free process that provides results with single-cell level sensitivity in from ninety minutes to four hours.

The IC 3D instrument converts blood samples into billions of minute droplets. Fluorescent DNA sensor solution infused into the droplets detects those with bacterial markers, marking them with an intense fluorescent signal. Separating the samples using real-time, DNAzyme-based sensors, droplet microencapsulation, and a high-throughput 3D particle counter system minimizes the interference of other components in blood, making it possible to directly detect target bacteria without the purification typically required in conventional assays.

Using Escherichia coli as a target, the investigators demonstrated that the IC 3D system could provide absolute quantification of both stock and clinical isolates of E. coli in spiked blood within a broad range of extremely low concentration from one to 10,000 bacteria per milliliter with exceptional robustness and limit of detection in the single digit range.

“We are extremely excited about this technology because it addresses a long-standing unmet medical need in the field,” said senior author Dr. Weian Zhao, assistant professor of pharmaceutical sciences at the University of California, Irvine. “As a platform technology, it may have many applications in detecting extremely low-abundance biomarkers in other areas, such as cancers, HIV and, most notably, Ebola.”

The study was published in the November 13, 2014, online edition of the journal Nature Communications.

Related Links:

University of California, Irvine


Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.